ILLUMINA INC. DL-,01 | 314.90 / +0.33% |
Date/Time | 01/18 / 13:30 |
Chg. / Chg.(%) | 1.05 / +0.33% |
Bid | 310.45 / 37 |
Ask | 315.50 / 15 |
Open | 310.60 |
Previous Close | 313.85 |
High | 314.90 |
Low | 310.60 |
Volume [EUR] | 10,348.25 |
Volume [Units] | 33 |
Price fixings | 3 |
ISIN | US4523271090 |
Security | ILU |
Exchange | Xetra |
Type | Stock |
Exchange | Last | Volume | |
---|---|---|---|
TradeGate | 311.150 | ![]() |
372 |
Xetra | 314.90 | ![]() |
33 |
Frankfurt | 312.7500 | ![]() |
31 |
Stuttgart | 312.650 | ![]() |
17 |
gettex | 311.500 | ![]() |
17 |
München | 315.70 | ![]() |
15 |
Berlin | 312.20 | ![]() |
10 |
Vienna Globa.. | 311.55 | ![]() |
0 |
Düsseldorf | 310.95 | ![]() |
0 |
Lang & Schwa.. | 310.950 | ![]() |
|
NASDAQ | 376.3500 | ![]() |
1,873,427 |
IEX | 376.53 | ![]() |
102,437 |
Cboe US | 376.48 | ![]() |
100,985 |
London Inter.. | 379.66 | 4,394 | |
Mexico | 7,265.00 | ![]() |
29 |
News
- Day Four of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Solves Genetic Mysteries, Enables Study of Complex Genetic Diseases, Simplifies Muscular Dystrophy Testing
01/15/2021 / 14:00 - GlobeNewswire - Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
01/11/2021 / 20:05 - GlobeNewswire - Pacific Biosciences Announces Appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer
01/08/2021 / 14:45 - GlobeNewswire - CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to Its 14th Year of Meteoric Growth, Digital Leadership, and Community Gratitude
12/23/2020 / 21:43 - GlobeNewswire - Publication Reveals in Side-by-Side Comparison that Method Using PacBio Sequencing Detects Only 72% of the Large Structural Variants Detected by Optical Genome Mapping with Saphyr
12/23/2020 / 14:00 - GlobeNewswire